CD30: a new target for ALL?
Leuk Lymphoma
.
2014 Mar;55(3):478-9.
doi: 10.3109/10428194.2013.823496.
Epub 2013 Aug 13.
Authors
Amir T Fathi
1
,
Yi-Bin Chen
Affiliation
1
Massachusetts General Hospital Cancer Center, Harvard Medical School , Boston, MA , USA.
PMID:
23837494
DOI:
10.3109/10428194.2013.823496
No abstract available
Publication types
Comment
MeSH terms
Female
Humans
Ki-1 Antigen / metabolism*
Male
Precursor Cell Lymphoblastic Leukemia-Lymphoma / metabolism*
Substances
Ki-1 Antigen